Carnivac-Cov
Carnivac-Cov[1][2][3] or Karnivak-Kov[4][3] is the first veterinary vaccine against COVID-19.[3] It is an inactivated vaccine for carnivores such as dogs, cats, foxes, arctic foxes and mink.[1] It was developed by the Federal Service for Veterinary and Phytosanitary Supervision of Russia[5] to help prevent mutations in animals that can occur in cross-species transmission,[1][3] as is suspected to have occurred with the Cluster 5 variant in Denmark in November 2020.[4]
The vaccine is given in 2 doses 21 days apart.[2] In trials, the tested animals sustained an immune response for at least six months.[1] The full course costs 500 ₽ (US$7).[2]
Clinical trials on animals began in October 2020.[6] The vaccine was registered in Russia on 31 March 2021,[1] where production began on 30 April[7] and administration began on 26 May.[8]
References
- "Russia registers world's first COVID-19 vaccine for animals". Reuters. Moscow. 31 March 2021. Retrieved 21 January 2022.
- "Russia Rolls Out Covid-19 Vaccine for Animals". The Wall Street Journal. 27 May 2021. Retrieved 21 January 2022.
- Chavda VP, Feehan J, Apostolopoulos V (10 June 2021). "A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals". Vaccines. 9 (6): 631. doi:10.3390/vaccines9060631. hdl:11343/287299. PMC 8228738. PMID 34200587.
- "From hippos to hamsters: how Covid is affecting creatures great and small". The Guardian. 11 December 2021. Retrieved 21 January 2022.
- "Russia launches vaccination of animals against COVID-19". TASS. 27 May 2021. Retrieved 21 January 2022.
- "Russia registers 'world's first' COVID-19 vaccine for animals". Al Jazeera. 31 March 2021. Retrieved 21 January 2022.
- "Russia launches production of coronavirus vaccine for animals". TASS. 30 April 2021. Retrieved 21 January 2022.
- "Covid: Russia starts vaccinating animals". BBC News. 26 May 2021. Retrieved 21 January 2022.